Aquestive Therapeutics Inc. Stock Prediction and Forecast [AQST]

AI-generated source summary

The analysis focuses on Aquestive Therapeutics (AQST), highlighting its recent strong buy candidate rating with a score of 6.94. The stock has shown an impressive gain of nearly 20% since its initial categorization, equating to approximately 1.3% per day. The stock is showing a short-term upward trend, with potential support at $5.79. According to fan theory, the potential peak level could be $7.01. The 3-month trend suggests a potential change of approximately 36.98%, with a return ranging between 4.60% and 32.46%. For the last trading day, the stock closed at $5.99, which is +13.88%. Trading volume is increasing along with the price and the stock showed an average daily volatility of 8.74% and a very high risk. Insider trading power is positive at 63.503, while analyst ratings show a general sell advice. The P/E ratio is negative, and it may open higher by approximately 8.3 cents and start trading at $6.07.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   27 Sept 2025, 03:21 UTC

   The analyst published the original source item.

2. First prediction resolved

   29 Sept 2025, 17:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   29 Sept 2025, 17:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.